SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-039001
Filing Date
2022-10-31
Accepted
2022-10-31 11:22:26
Documents
4
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A ny20005565x2_def14a.htm DEF 14A 643325
2 ny20005565x2_pc1.jpg GRAPHIC 593075
3 ny20005565x2_pc2.jpg GRAPHIC 424832
4 sig_yniihara.jpg GRAPHIC 21048
  Complete submission text file 0001140361-22-039001.txt   2074652
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35527 | Film No.: 221344583
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences